| 391 |
Ciprofloxacin
|
-
Ciprofloxacin, CAS-RN: 85721-33-1, DTXSID8022824
|
2 AOPs
|
| 707 |
Cisapride
|
-
Cisapride, CAS-RN: 81098-60-4, DTXSID3022825
|
2 AOPs
|
| 716 |
Cisplatin
|
-
Cisplatin, CAS-RN: 15663-27-1, DTXSID4024983
|
472: DNA adduct formation leading to kidney failure
|
| 406 |
CITCO
|
-
CITCO, CAS-RN: 338404-52-7, DTXSID4040761
|
None
|
| 463 |
Citral
|
|
297: Inhibition of retinaldehyde dehydrogenase leads to population decline
|
| 191 |
Clofibrate
|
-
Clofibrate, CAS-RN: 637-07-0, DTXSID3020336
|
3 AOPs
|
| 735 |
Clomiphene
|
-
Clomiphene, CAS-RN: 911-45-5, DTXSID1022843
|
None
|
| 734 |
Clomiphene citrate (1:1)
|
-
Clomiphene citrate (1:1), CAS-RN: 50-41-9, DTXSID8020337
|
440: Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia
|
| 262 |
Clonixin
|
-
Clonixin, CAS-RN: 17737-65-4, DTXSID2046121
|
152: Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity
|
| 292 |
Clotrimazole
|
-
Clotrimazole, CAS-RN: 23593-75-1, DTXSID7029871
|
None
|
| 511 |
Colcemid
|
-
Colcemid, CAS-RN: 477-30-5, DTXSID7020342
|
None
|
| 510 |
colchemid
|
|
None
|
| 124 |
Colchicine
|
-
Colchicine, CAS-RN: 64-86-8, DTXSID5024845
|
106: Chemical binding to tubulin in oocytes leading to aneuploid offspring
|
| 332 |
Colistin
|
-
Colistin, CAS-RN: 1066-17-7, DTXSID1040663
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 196 |
coumachlor
|
-
Coumachlor, CAS-RN: 81-82-3, DTXSID8041797
|
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 197 |
coumatetralyl
|
-
Coumatetralyl, CAS-RN: 5836-29-3, DTXSID8041799
|
187: Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage
|
| 527 |
COVID-19
|
|
None
|
| 848 |
Cucurbitacin B
|
|
606: Ecdysone receptor antagonism leading to mortality via inhibition of chitin synthase 1
|
| 849 |
Cucurbitacin D
|
|
606: Ecdysone receptor antagonism leading to mortality via inhibition of chitin synthase 1
|
| 842 |
CuO nanoparticles
|
|
590: Increase of intracellular copper leading to cuproptosis via interference with energy metabolism
|
| 612 |
curcumin
|
-
Curcumin, CAS-RN: 458-37-7, DTXSID8031077
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 244 |
Cyasterone
|
|
4: Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1
|
| 783 |
Cyclizine
|
-
Cyclizine, CAS-RN: 82-92-8, DTXSID4022864
|
504: SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level
|
| 689 |
Cycloate
|
-
Cycloate, CAS-RN: 1134-23-2, DTXSID6032356
|
None
|
| 748 |
Cyclopamine
|
-
Cyclopamine, CAS-RN: 4449-51-8, DTXSID6043709
|
None
|